Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Chemspeed UK is Evolving

Published: Monday, October 17, 2005
Last Updated: Monday, October 17, 2005
Bookmark and Share
Chemspeed© Technologies have announced the opening of its new UK facilities.

The UK subsidiary of Chemspeed Technologies is moving to a new facility at the Northampton Science Park. Centrally located and with close links to the M1, M6 & A14, this specialized office facility will provide an improved level of service and support to all customers and partners.

The facility offers extended meeting room and presentation facilities, more office and product storage space and a 30 square meter chemistry support laboratory. Visitors are welcome at the new offices, starting 1 October 2005, to see some of the latest innovative equipment and accessories in action, and discuss their personal requirements with the Chemspeed team.

Guy Travers will serve as the new Business Manager to implement the transition to the expanded facilities and manage the growth of new technologies in the UK. Having worked for companies supplying equipment to the Pharmaceutical & Fine Chemical Industry of the UK for more than 10 years, Mr. Travers has extensive experience in the market.

Since 2000, he has been involved with the implementation of automated solutions for many companies and brings with him first-hand knowledge and know-how.

Richard Giles has been appointed to head the chemistry support services in the UK. Mr. Giles received his Ph.D. at Durham University, where he was responsible for implementing the automated development of bi-functional catalysts. He previously worked at the Process Research department at GSK (Tonbridge) and has published frequently in the Journal of Organometallic Chemistry. His professional experience will facilitate the ease of implementation of new technologies into specialized workflows.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More Than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Breakthrough Flu Vaccine Inhibited by Pre-existing Antibodies
Universal truths – how existing antibodies are sabotaging the most promising new human flu vaccines.
New Medication Shows Promise Against Liver Fibrosis in Animal Studies
Liver fibrosis is a gradual scarring of the liver that puts people at risk for progressive liver disease and liver failure.
Raw Eggs Deemed Safe to Eat
A report published today by the Advisory Committee on the Microbiological Safety of Food (ACMSF) into egg safety has shown a major reduction in the risk from salmonella in UK eggs.
Monitoring TTX Toxin in Shellfish
In a number of small studies, mussels and oysters from the eastern and northern part of the Oosterschelde in Holland were found to contain tetrodotoxin (TTX).
Gene Terapy for Muscle Wasting Developed
New gene therapy could save millions of people suffering from muscle wasting disease.
NIH Begins Yellow Fever Vaccine Trial
NIH has initiated an early-stage clinical trial of a vaccine to protect against yellow fever.
Gene-Editing 'Toolbox' Targets Multiple Genes Simultaneously
Researchers have designed a system that modifies, or edits, multiple genes in a genome at once while minimising unintentional effects.
Detecting Alzheimer's with Smell Test
Odour identification test may offer low-cost alternative for predicting cognitive decline and detecting early-stage Alzheimer’s disease.
Antibody Drug Shows Promise in HIV Treatment
Researchers are a step closer to an alternative HIV treatment that has the potential for lasting effects and less frequent dosing.
Testing Nanoparticle Drug Delivery in Dogs
Scientists have tested a nanoparticle drug delivery against bone cancer in dogs with promising results.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!